Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
Adi Zundelevich, Maya Dadiani, Smadar Kahana‐Edwin, Amit Itay, Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, Anya Pavlovski, Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam
Abstract
After the publication of the original article [1], we were notified the upper panel of the Fig. 1, where the patients' codes are listed, was cropped by mistake so the patients 1-8 are repeated.
Topics & Concepts
Surgical oncologyMedicineEndocrine systemBreast cancerOncologyMetastatic breast cancerInternal medicineCancerBioinformaticsHormoneBiologyGlutathione Transferases and PolymorphismsFerrocene Chemistry and ApplicationsEstrogen and related hormone effects